Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kissei Pharmaceutical Co. Ltd. (4547:JPX), powered by AI.
Kissei Pharmaceutical Co. Ltd. is currently trading at ¥3,900. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kissei Pharmaceutical Co. Ltd. on Alpha Lenz.
Kissei Pharmaceutical Co. Ltd.'s P/E ratio is 14.2.
“Kissei Pharmaceutical Co. Ltd. trades at a P/E of 14.2 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 10.5% highlights clear growth momentum.”
Ask for details →Kissei Pharmaceutical Co. Ltd. is a pharmaceutical company based in Japan focused on developing, manufacturing, and marketing a range of medicinal products. Established in 1946, Kissei is dedicated to improving healthcare solutions and advancing medical care through innovative pharmaceutical treatments. The company’s primary areas of concentration include urology, nephrology, dialysis, and metabolism. Kissei is recognized for its contributions to improving patients' lives with treatments specially designed for these critical areas. It engages in both prescription and over-the-counter medications, ensuring accessibility across diverse healthcare needs. The company collaborates with research institutions to stay at the forefront of medical research, emphasizing new drug development. In the financial market, Kissei Pharmaceutical Co. Ltd. plays a vital role in the health sector, providing investors an opportunity to engage with the growing demand for advanced medical treatments driven by an aging global population and the need for improved therapeutic solutions. Listed on the Tokyo Stock Exchange, the company underlines its commitment to innovation and contributing to global health, underpinning its significance in the pharmaceutical industry.
“Kissei Pharmaceutical Co. Ltd. trades at a P/E of 14.2 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 10.5% highlights clear growth momentum.”
Ask for details →Kissei Pharmaceutical Co. Ltd. (ticker: 4547) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,778 employees. Market cap is $170.1B.
The current price is 3,900 with a P/E ratio of 14.22x and P/B of 0.81x.
ROE is 5.58% and operating margin is 6.54%. Annual revenue is $88.3B.